News

SNMMI is a one-stop resource for all nuclear medicine and molecular imaging news.  The society monitors news daily and shares relevant news from the field on its website.

Articles
Data pager
Data pager
Page size:
PageSizeComboBox
select
 141 items in 8 pages
Show all 141
Reston, VA—Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy (177Lu-PSMA) beyond six cycles is an effective and well-tolerated treatment for metastatic castration-resistant prostate cancer patients, according to
Subject: Press Release, SNMMI News
Jun 26, 2024
6/26/2024 12:27:12 PM
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians, technologists, pharmacists, laboratory professionals, scientists and others earlier this week at its 2024 Annual Meeting in Toronto, Ontario. Themed “Inn
Subject: Press Release, SNMMI News
Jun 12, 2024
6/12/2024 7:00:00 AM
A comparative analysis between FAPI and 18F-FDG PET/CT for the systemic staging of newly diagnosed breast cancer shows that FAPI PET/CT is more accurate in staging patients. Nearly 20 percent of patients were restaged by FAPI PET/CT, indicating the r
Subject: Press Release, SNMMI News
Jun 11, 2024
6/11/2024 10:45:00 AM
A newly developed chelator can significantly reduce off-target toxicity in prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Mee
Subject: Press Release, SNMMI News
Jun 11, 2024
6/11/2024 10:45:00 AM
Combination of alpha- and beta-radionuclide therapy is feasible, tolerable, and effective for colorectal cancer, according to preclinical research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual meeting. This new approa
Subject: Press Release, SNMMI News
Jun 11, 2024
6/11/2024 9:15:00 AM
A new ultra-low dose imaging method used with long axial field-of-view PET scanners can obtain images with a historically low radiopharmaceutical dose—more than 50 times lower than the standard effective dose. Furthermore, the technique can generate
Subject: Press Release, SNMMI News
Jun 11, 2024
6/11/2024 9:15:00 AM
A newly developed radiotracer can generate high quality and readily interpretable images of cardiac amyloidosis, a condition referred to as the “Alzheimer’s disease of the heart.” As the first amyloid-specific and pan-amyloid binding radiotracer desi
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 2:00:00 PM
A novel AI approach can accurately detect six different types of cancer on whole-body PET/CT scans, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. By automatically quantifying tumor burde
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 11:15:00 AM
David M. Goldenberg, MD, known for his pioneering work in monoclonal antibodies and immunotherapy, was awarded the Benedict Cassen Prize during the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting. This honor is awarded every two
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
Michael J. Evans, PhD, a chemical biologist known for his innovative approaches to imaging and treating a diverse array of diseases, has been named the 2024 recipient of the prestigious Sam Gambhir Trailblazer Award. The Society of Nuclear Medicine a
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
Cathy Sue Cutler, PhD, FSNMMI, chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduc
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
Heather Jacene, MD, assistant chief of Nuclear Medicine and Molecular Imaging at Brigham and Women’s Hospital, clinical director of Nuclear Medicine at Dana-Farber Cancer Institute, and associate professor of Radiology at Harvard Medical School in Bo
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
Jean-Luc C. Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2024 Annual
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never before seen or quantified. With its ultra-high sensitivity and resolution, the NeuroEXPLORER provides exceptional brain PET images and has the po
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
The Society of Nuclear Medicine and Molecular Imaging recognized six new SNMMI Fellows today during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. The SNMMI Fellowship was established in 2016 to recognize distingui
Subject: Press Release, SNMMI News
Jun 10, 2024
6/10/2024 9:30:00 AM
The presence of beta-amyloid deposits in the brain significantly limits the effectiveness of cognitive training in healthy older adults, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.
Subject: Press Release, SNMMI News
Jun 09, 2024
6/9/2024 4:45:00 PM
The use of hearing aids can help to slow the metabolic decline that takes place in the brains of adults with mild cognitive impairment, according to research presented at the 2024 Society of Nuclear Medicine and Molecular Imaging Annual Meeting. Thos
Subject: Press Release, SNMMI News
Jun 09, 2024
6/9/2024 4:45:00 PM
A novel imaging approach—68Ga-DOTATATE PET/CT—can more accurately differentiate residual/recurrent tumors from post-surgery scar tissue in patients with head and neck paragangliomas (HNPGLs) compared to MRI. Providing functional information about the
Subject: Press Release, SNMMI News
Jun 09, 2024
6/9/2024 4:45:00 PM
Cybil Nielsen, MBA, CNMT, FSNMMI-TS, nuclear medicine educator at Gurnick Academy of Medical Arts in Concord, California, has been elected as the 2024-25 president-elect for the Society of Nuclear Medicine and Molecular Imaging Technologist Section (
Subject: Press Release, SNMMI News
Jun 09, 2024
6/9/2024 2:00:00 PM
Julie Dawn Bolin, MS, CNMT, program director of Nuclear Medicine Technology at GateWay Community College in Phoenix, Arizona, and nuclear medicine technologist at Banner University Medical Center in Tucson, Arizona, has been elected as the 2024-25 pr
Subject: Press Release, SNMMI News
Jun 09, 2024
6/9/2024 2:00:00 PM